アントラサイクリン抗生物質の使用によって誘発される腫瘍細胞の化学抵抗のメカニズムにおけるオートファギーの役割

Nadezhda A Persiyantseva¹, Ekaterina S Ivanova^1,2, Maria A Zamkova^3,2

¹Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, 115478, Russia.

Biochemistry. Biokhimiia

|August 31, 2025

まとめ

オートファギーは癌治療において二重の役割を担っています腫瘍細胞を化学療法から守る一方で腫瘍細胞をブロックすると治療に敏感になり化学抵抗に複雑な影響を及ぼすことがわかります

科学分野:

細胞生物学
分子生物学
癌研究

背景:

オートファギーは損傷した部位を分解する細胞のプロセスです
アントラサイクリン (Anthracycline) は,オートファギーを誘発する化学療法薬です.
癌治療におけるオートファギーの役割は複雑で文脈に依存している.

研究の目的:

アントラサイクリン化学療法に対する腫瘍細胞の反応におけるオートファギーの二重の役割を調査する.
細胞抵抗と細胞生存に自動食性の調節がどのように影響するかを調べる

主な方法:

薬理学的および遺伝的アプローチを用いて,オートファギーを阻害または活性化します.
アントラサイクリンで治療された腫瘍細胞系に対する自己消化調節の効果を分析した.

主要な成果:

アントラサイクリンによって誘発された自殺は,しばしば細胞保護性であり,化学抵抗性を高めます.
腫瘍細胞をアントラサイクリンに敏感にする.
過剰なオートファギーの活性化はオートファギーの細胞死につながる.
いくつかの文脈では,アントラサイクリンが細胞毒性オートファギーを誘導し,それを遮断すると細胞の生存が向上する.

結論:

調節されたオートファギーは腫瘍細胞の生存と死の両方に影響を与える双刃の剣です
オートファジー経路をターゲットにすることで,化学抵抗を克服する新しい戦略を提供できますが,特定の文脈を慎重に考慮する必要があります.

キーワード:

アントラサイクリン抗生物質オートファジー細胞死化学抵抗性化学療法ドクソルビシン治療による老化腫瘍細胞

さらに関連する動画

09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.0K

19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.8K

関連する概念動画

01:27

Autophagy

4.6K

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...

4.6K

02:56

Treatment Resistant Cancers

3.4K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

3.4K

01:36

Delivery Pathways to the Lysosome

7.0K

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...

7.0K

01:18

Autophagic Cell Death

3.5K

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

3.5K

02:50

Combination Therapies and Personalized Medicine

5.1K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

5.1K

02:57

Targeted Cancer Therapies

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...